Company ProfilePremium

Bampsl Securities Limited

Company Profile Analysis

Ticker: 531591.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Bampsl Securities Limited - Company showcase

Year Founded & Workforce

1995

2 Employees

Bampsl Securities Limited logo

Bampsl Securities Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Bampsl Securities Limited Overview

Bampsl Securities Limited is a nano-cap, Delhi-based, non-deposit-taking NBFC that has been listed on BSE since its February 1996 IPO. It operates essentially as a proprietary securities-trading and investment house with a growing loan book: the company buys and sells listed shares on its own account (recorded as sale of stock-in-trade), engages in jobbing, hedging and investment activity, and extends short- and long-term financial accommodation to borrowers. With two employees, no borrowings, total assets of about ₹40 Cr and net worth of about ₹39.9 Cr (FY2026), it is effectively a small balance sheet deployed by its promoter-MD in capital markets and lending. Revenue scaled from ₹0.31 Cr (FY2022) to ₹25.22 Cr (FY2026), but thin trading margins and a ₹2.5 Cr bad-debt provision in FY2026 kept net profit at ₹0.40 Cr and ROE near 1%. Promoter holding is low (10.83%) and has been unchanged for nearly a decade.


The company's own description

In its exchange filings and annual-report-derived summaries, the company describes itself as a non-systemically-important, non-deposit-taking NBFC whose business is dealing and investing in shares and other securities, alongside financial services such as spot financing, short-term financial accommodation, long-term financial accommodation and related activities. It states that it deals in shares and securities for its own account and maintains records accordingly, and that it is engaged in securities jobbing, hedging and investment activities (source: Screener "About" section citing the FY2024 annual report, pages 10, 17 and 59; IIFL company summary). On inception the company invested funds in the primary capital market; securities trading commenced in 1995.

Several aggregator profiles (Kotak Securities, ICICIdirect, Tradomate) state that the company operates in the cash market segment of BSE and in the capital market and futures & options segments of "NSE", expanding "NSE" erroneously as the "Nairobi Stock Exchange". This is a propagated data-vendor error; in the Indian context NSE refers to the National Stock Exchange of India.

In its FY2026 financial results the company stated that it operates in a single operating segment, described as "securities broking" (ScanX, May 2026). MarketScreener/Zonebourse labels the single revenue line "Trading in Shares & Financing Services". The description "broking" is somewhat at odds with the income mix (principally sale of proprietary stock-in-trade plus interest income); no third-party brokerage revenue is separately reported in accessed sources.

Independent characterisation

Analytically, Bampsl is best understood as a promoter-run proprietary investment vehicle with a lending sideline, wrapped in an NBFC licence:

Proprietary trading: In FY2026, sale of stock-in-trade was ₹2,173.79 lakh (₹21.74 Cr), down 7.2% from about ₹2,343 lakh in FY2025, and represented roughly 86% of revenue from operations (ScanX FY2026 annual-report summary, Sep 2026). Because trading revenue is reported on a gross basis (sale value of shares), headline revenue materially overstates economic activity; the relevant economic measure is the trading spread, which is small.

Lending: Interest income jumped to ₹348.66 lakh (₹3.49 Cr) in FY2026 from ₹18.86 lakh in FY2025, and long-term loans and advances stood at ₹3,258.13 lakh (₹32.58 Cr) at 31 March 2026 against total assets of ₹4,005.30 lakh (ScanX, Sep 2026). In balance-sheet terms the company is therefore predominantly a lender: loans and advances are about 81% of total assets.

Credit risk realisation: FY2026 included a ₹250 lakh bad-debt provision, which exceeded the year's pre-provision operating surplus and drove a 70% fall in net profit (ScanX, Sep 2026).

Scale: Two employees; no borrowings in any year from FY2015 to FY2026 (Screener); fixed assets of ₹0.29 Cr.

Revenue model mix

Revenue typeFY2026 (INR Lakh)FY2025 (INR Lakh)CharacterSource
Sale of stock-in-trade (proprietary trading)2,173.792343.00 (approx., derived)Transactional; gross sale valueScanX FY2026 AR summary
Interest income (loans/advances)348.6618.86Spread-based lendingScanX FY2026 AR summary
Revenue from operations (total)2,522.452,361.86—ScanX FY2026 AR summary
Other income0.0248.55 (incl. bad-debt recovery 48.53)Non-recurringScanX FY2026 AR summary
Total income2,522.472,410.41—ScanX; IIFL Directors' Report FY2025

Product vs. service vs. subscription vs. licensing: not applicable in the conventional sense; the model is 100% financial-services (trading income plus interest). No subscription or licensing revenue exists.

Value-chain position, customers and end-markets

Value-chain position: Principal/proprietary market participant and small-ticket lender, not an intermediary serving retail clients at scale.

Customer types: Counterparties in exchange trades (anonymous) and borrowers of loans/advances. Identity, concentration and sector of borrowers are not publicly disclosed in accessed sources; given the size of the loan book relative to the two-person organisation, concentration risk is likely high (analyst inference, not company disclosure).

End-markets: Indian listed equities (cash and possibly derivatives segments) and Indian non-bank credit. Geography: 100% India (Zonebourse geographic split).

Strategy

Stated strategy. The company publishes no investor presentation, investor-day material or earnings-call transcripts, and no medium-term strategy statement was found in accessed sources. The FY2026 annual report's dividend rationale indicates the board withheld a dividend to preserve liquidity for business expansion plans (ScanX, Sep 2026); the nature, size and timing of those plans are not disclosed.

Observable strategic moves (last 24 months):

Transformation programmes, new business launches, partnerships, platform investments, sustainability/ESG commitments, cost programmes with targets: none disclosed. Management financial targets/guidance: none publicly issued.

Products & Services

The company has no branded products, platforms or client-facing offerings. Its "catalogue" consists of the activity lines described in its filings.

Key specifications such as loan tenor, yield, collateral, ticket size, borrower profile and portfolio composition of stock-in-trade (quoted vs unquoted) are not publicly disclosed in accessed sources.

An implied FY2026 yield on loans can be approximated: interest income ₹3.49 Cr / long-term loans ₹32.58 Cr ≈ 10.7% (analyst calculation; uses year-end balance and ignores short-term advances, so indicative only).

Product Portfolio

#Activity lineDescriptionTarget counterpartySincePricing modelFlagship / named offeringSource
1

Proprietary equity trading (cash market)

Buying and selling listed shares on own account; recorded as stock-in-trade

Exchange counterparties

1995

Trading spread / capital gain

None named

IIFL; ScanX FY2026

2

Derivatives / hedging activity

Hedging and F&O activity referenced in company description

Exchange counterparties

—

Spread

None named

Kotak; ICICIdirect

3

Securities jobbing

Short-term market-making/jobbing in securities

Exchange counterparties

—

Spread

None named

IIFL

4

Investment in shares and securities

Holding securities for investment

—1995

Dividends / capital gains

None named

IIFL

5

Spot financing

Immediate short-term funding

——

Interest

None named

IIFL; Screener

6

Short-term financial accommodation

Short-tenor loans/advances

——

Interest

None named

IIFL; Screener

7

Long-term financial accommodation

Longer-tenor loans/advances; ₹32.58 Cr outstanding at FY2026

——

Interest

None named

ScanX FY2026

“—” = not publicly disclosed.

Financial Narrative

All figures standalone, ₹ Cr, source Screener.in (C-MOTS data linked to BSE filings) unless stated. Ratios are analyst calculations from those figures unless attributed.

Income statement

EPS diluted: not separately disclosed in accessed sources; with no convertible instruments known, diluted EPS is expected to equal basic.

Discrepancies: FY2025 net profit is ₹135.16 lakh in the company's FY2026 results release (ScanX, May 2026) versus ₹135.10 lakh in the ScanX summary of the FY2026 annual report (Sep 2026); immaterial. FY2025 total income per the Directors' Report is ₹2,410.41 lakh (IIFL), reconciling to Screener's ₹23.62 Cr operations + ₹0.49 Cr other income.

Margins

Gross profit / gross margin: not meaningfully disclosed. ScanX labels "total revenue minus total expenses" as gross profit (₹61.45 lakh FY2026; ₹182.11 lakh FY2025), which is in substance pre-tax profit; a conventional gross margin (sale of stock-in-trade minus purchases and inventory change) is not available in accessed sources.

Growth

Revenue CAGR: 5-year (FY2021 ₹0.54 Cr to FY2026 ₹25.22 Cr) ≈ 116%; 3-year (FY2023–FY2026) ≈ 101%; 10-year ≈ -6% (Screener). Net profit CAGR: 5-year 82%, 3-year -2%, TTM -79% (Screener).

Balance sheet

FY2026 composition (ScanX summary of annual report, Sep 2026): total assets ₹4,005.30 lakh; long-term loans and advances ₹3,258.13 lakh; trade receivables ₹390.82 lakh (+38.4% YoY, implying about ₹282 lakh at FY2025).

Cash & equivalents: not separately disclosed in accessed sources; Zerodha's data shows net debt of -₹0.01 Cr at March 2025, implying cash of roughly ₹0.01 Cr. Net debt: approximately zero to marginally negative throughout. Working capital: not computable from accessed data (current/non-current split unavailable); Screener reports working-capital days falling from 138 to 101 and debtor days rising from 37.2 to 56.6.

Discrepancy: the ScanX summary of Q2 FY2026 results (Oct 2025) reported total assets of "₹41,020.90 lakh" and total equity of "₹40,524.10 lakh" at 30 Sep 2025; these are about ten times the annual balance sheet and are almost certainly a unit transcription error for ₹4,102.09 lakh and ₹4,052.41 lakh (≈₹41.0 Cr and ₹40.5 Cr).

Cash flow

The mirror-image pattern of operating and investing cash flows (e.g., FY2025: -₹2.74 Cr operating, +₹2.73 Cr investing) indicates that loan disbursements/trading working capital are funded by liquidating investments or advances classified in investing activities, with net cash essentially flat at near zero. The company has never raised external debt and has not raised equity since FY2018.

Ratios

ROE figures are from Screener; ROA, ROCE and asset turnover are analyst calculations. Current ratio, interest coverage, net debt/EBITDA and cash conversion cycle: not meaningful or not publicly disclosed (no interest expense; no current/non-current split in accessed data; net debt ≈ 0). Screener's current snapshot gives ROCE 1.54% and ROE 1.01%, and a 3-year average ROE of 1.84%.

Quarterly trend (last 9 quarters)

Source: Screener standalone quarterly results.

Quarterly discrepancies to note:

Q2 FY2025 restatement: The Q2 FY2026 release compared net profit of ₹52.59 lakh with ₹54.83 lakh for Q2 FY2025 (ScanX, Oct 2025), whereas Screener shows Q2 FY2025 net profit of ₹0.06 Cr. The difference is consistent with Ind AS restatement of comparatives but is unexplained in accessed sources.

H1 FY2026 income: ScanX reported H1 FY2026 total income from operations of ₹3,110.74 lakh, which exceeds the full-year FY2026 revenue of ₹2,522.45 lakh and Screener's H1 figure of ₹11.78 Cr. This is unreconciled; the ScanX figure may reflect a gross presentation later revised or a transcription error.

Q1 FY2027 income composition: ScanX reports net sales of ₹83.53 lakh plus other operating income of ₹360.76 lakh (≈₹4.44 Cr total) versus Screener's ₹3.61 Cr revenue; Q1 FY2026 comparatives were ₹87.05 lakh and ₹865.08 lakh (≈₹9.52 Cr) versus Screener's ₹8.65 Cr. Net profit figures reconcile (₹53.58 lakh vs ₹0.54 Cr). The company resubmitted its Q1 FY2027 results to BSE on 11 Sep 2026 (Screener announcements), which may account for differences between data sets.

Commentary on trends, inflections and drivers

Revenue inflection (FY2023–FY2025). After a near-dormant FY2020–FY2022 (revenue ₹0.31–1.86 Cr), revenue scaled roughly 76-fold to ₹23.62 Cr by FY2025. Because revenue is predominantly gross sale value of proprietary stock, this reflects higher trading turnover rather than proportionate value creation; operating margin peaked at only 5.6% in FY2025. The timing coincides with a strong Indian small-cap equity market, suggesting turnover is market-driven.

Mix shift to lending (FY2026). Interest income rose about 18-fold to ₹3.49 Cr, while trading sales fell 7.2%. This is the most consequential strategic change visible in the numbers: it shifts the earnings driver from trading spreads to credit spreads, and with it the risk from market risk toward credit risk.

Credit cost shock (FY2026). A ₹2.50 Cr bad-debt provision (no comparable charge in FY2025, when there was instead a ₹0.49 Cr bad-debt recovery) pushed Q4 FY2026 to a ₹1.27 Cr net loss and full-year profit down 70%. The provision equals about 7.7% of the year-end long-term loan book, which is high for a book that only recently began generating material interest income.

Profit quality. Other income contributed most of the pre-tax profit in FY2022–FY2024 (e.g., FY2024: other income ₹0.63 Cr vs PBT ₹0.49 Cr); FY2025 was the first year in the series in which core operations generated most of the profit, and FY2026 core profit (₹0.61 Cr) was achieved despite the provision only because pre-provision operating profit was about ₹3.1 Cr (analyst inference: ₹0.61 Cr + ₹2.50 Cr).

Capital efficiency. ROE has stayed between -1.3% and 3.5% for 12 years. With equity of ~₹39.9 Cr and no leverage, even the FY2025 peak profit implied a sub-4% ROE. The balance sheet has grown only from ₹37.0 Cr (FY2015) to ₹40.1 Cr (FY2026).

Tax rate. The effective rate climbed from 16% (FY2022) to 34.4% (FY2026), the latter elevated by the provision's tax treatment.

Recent run-rate. Q1 FY2027 net profit of ₹0.54 Cr equals roughly 1.35x full-year FY2026 profit, but it is a single quarter and follows the volatile Q4.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Revenue by Segment (%)

SegmentFY2022FY2023FY2024FY2025FY2026

Trading in Shares & Financing Services revenue (INR Cr)

0.313.128.3823.6025.22

Share of total revenue (%)

100100100100100

YoY growth (%)

-409141691827

Results by Segment and Segment Margins & Growth (%)

MetricFY2022FY2023FY2024FY2025FY2026

Segment pre-tax income (INR Cr)

0.250.520.491.820.61

Segment pre-tax margin (%)

80.616.75.87.72.4

Operating (financing) profit (INR Cr)

0.06-0.03-0.131.330.61

Income line (INR Lakh)

Income line (INR Lakh)FY2025FY2026

Sale of stock-in-trade

2,343.002,173.79

Interest income

18.86348.66

Other income

48.550.02

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

0.313.128.3923.6225.22

Total expenses excl. interest & depreciation (INR Cr)

0.253.158.5222.2924.61

Operating (financing) profit (INR Cr)

0.06-0.03-0.131.330.61

Other income (INR Cr)

0.200.560.630.490.00

Interest expense (INR Cr)

0.000.000.000.000.00

Depreciation (INR Cr)

0.010.010.010.000.00

EBITDA (INR Cr, PBT + interest + depreciation)

0.260.530.501.820.61

Pre-tax income (INR Cr)

0.250.520.491.820.61

Effective tax rate (%)

16.0017.3120.4125.8234.43

Net income (INR Cr)

0.200.430.391.350.40

EPS basic (INR)

0.060.130.110.400.12

Dividend per share (INR)

00000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin

MarginFY2022FY2023FY2024FY2025FY2026

Operating (financing) margin (%)

19.35-0.96-1.555.632.42

EBITDA margin (%)

83.917.06.07.72.4

Pre-tax margin (%)

80.616.75.87.72.4

Net margin (%)

64.513.84.65.71.6

Growth metric

Growth metricFY2022FY2023FY2024FY2025FY2026

Revenue YoY (%)

-42.6906.5168.9181.56.8

Net income YoY (%)

900.0115.0-9.3246.2-70.4

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

37.5138.0038.3739.9640.06

Fixed assets (INR Cr)

0.320.300.290.290.29

Other assets incl. loans, stock-in-trade, receivables, cash (INR Cr)

37.1937.7038.0839.6739.77

Equity share capital (INR Cr)

34.0434.0434.0434.0434.04

Reserves (INR Cr)

3.243.674.075.425.82

Total equity (INR Cr)

37.2837.7138.1139.4639.86

Total debt (INR Cr)

00000

Short-term debt (INR Cr)

00000

Long-term debt (INR Cr)

00000

Other liabilities (INR Cr)

0.230.290.260.500.20

Goodwill & intangibles (INR Cr)

00000

Book value per share (INR)

10.9511.0811.2011.5911.71

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Cr)

-2.010.010.00-2.74-0.08

Investing cash flow (INR Cr)

2.02-0.020.022.730.08

Financing cash flow (INR Cr)

00000

Net cash flow (INR Cr)

0.000.000.02-0.010.00

Capex (INR Cr)

00000

Free cash flow (INR Cr)

-2.010.010.00-2.74-0.08

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%)

0.541.151.033.481.01

ROA (%)

0.531.131.023.381.00

ROCE / ROIC proxy (%)

0.671.381.294.611.53

Debt to equity (x)

00000

Asset turnover (x)

0.0080.0820.2190.5910.630

Equity to assets (%)

99.499.299.398.799.5

Income Statement and Per-Share Data

MetricQ1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue (INR Cr)

6.755.006.665.218.653.136.886.563.61

Pre-tax income (INR Cr)

0.080.081.270.400.730.790.80-1.700.72

Net income (INR Cr)

0.030.060.960.310.540.530.60-1.270.54

EPS (INR)

0.010.020.280.090.160.160.18-0.370.16

Revenue by Region and Revenue by Region (%)

RegionFY2022FY2023FY2024FY2025FY2026

India revenue (INR Cr)

0.313.128.3823.6025.22

India share of total (%)

100100100100100

India revenue YoY growth (%)

-409141691827

Share Price History

DateShare price (INR)Market cap (INR Cr)Source

19 Apr 2024

8.7729.85

Equitymaster

3 Jul 2024 (approx.)

8.9830.6

Screener (cached)

31 Dec 2024

12.0141

Business Standard

14 Oct 2025

17.60

Not stated

Angel One

18 Dec 2025

21.0372

Business Standard

14 May 2026

19.2564.8

ICICIdirect; Musaffa

12 Jun 2026

18.3562.1

ICICIdirect; Fyers

9 Sep 2026

18.5563.27

Bajaj Broking

19 Oct 2026

17.9060.8

Screener

Share Price & Returns

HorizonReturnSource

1 month

-3.25%

ScanX (20 Oct 2026)

6 months

-7.93%

ScanX

1 year

+1% (Screener CAGR) / -1.97% (ScanX)

Screener; ScanX (vendors differ on reference dates)

3 years (CAGR)

23%

Screener

5 years (CAGR)

41%

Screener

10 years (CAGR)

19%

Screener

Valuation Snapshot

MultipleValueBasisSource

P/E (TTM)

152x

TTM PAT ₹0.40 Cr

Screener

P/E (FY2026)

~149x

₹17.90 / EPS ₹0.12

Analyst calc.

P/B

~1.53x

Book value ₹11.7

Screener; analyst calc.

EV/Sales (FY2026)

~2.4x

EV ≈ mkt cap (no debt, ~nil cash) ₹60.8 Cr / ₹25.22 Cr

Analyst calc.

EV/Sales (TTM)

~3.0x

TTM revenue ₹20.18 Cr

Analyst calc.

EV/EBITDA (FY2026/TTM)

~100x

EBITDA ₹0.61 Cr

Analyst calc.

Dividend yield

0%—

Screener

Capital Markets

ItemStatusSource

Analyst coverage / consensus

None (0 analysts)

Simply Wall St

Dividend history

No dividend FY2015–FY2026; FY2026 dividend not recommended

Screener; ScanX

Dividend policy

Retention for liquidity/expansion (FY2026 rationale)

ScanX

Credit ratings (Moody's/S&P/Fitch or Indian agencies)

None; no rated debt

—

Debt maturity profile

Not applicable (no debt)

Screener

Pledged promoter shares

Nil (FY2026 declaration)

Company filing

Analyst Conclusions

Management guidance and consensus

Management provides no quantitative guidance and holds no earnings calls. No sell-side consensus exists (zero analysts). The only forward-looking statement identified is the FY2026 board's reference to conserving liquidity for business expansion plans.

Bull case

  1. Lending franchise forming: A ~10.7% implied yield on a ₹32.6 Cr book (FY2026) could, at normal credit costs, generate pre-provision operating profit of about ₹3 Cr a year (FY2026 pre-provision estimate ≈ ₹3.1 Cr), implying ROE near 6% on current equity, triple the 3-year average.

  2. Clean, unlevered balance sheet: Zero debt and 99.5% equity-to-assets give downside protection and room to grow the loan book with modest leverage.

  3. Earnings rebound visible: Q1 FY2027 PAT of ₹0.54 Cr already exceeds FY2026's full-year ₹0.40 Cr; four of the last five quarters were profitable at ₹0.53–0.60 Cr.

Bear case

  1. Credit quality is the core unknown: A ₹2.50 Cr provision against a newly built book, alongside 38% receivables growth and debtor days rising to 56.6, suggests underwriting risk that disclosures do not let investors assess.

  2. Valuation detached from returns: At ~1.5x book and ~150x trailing earnings for a business with a 12-year ROE range of -1.3% to 3.5%, the stock prices in a step-change in profitability not yet evidenced.

  3. Governance and reporting fragility: 10.83% promoter stake, combined Chair/MD, board attrition to about four directors, a BSE price-movement query, a results resubmission and unreconciled interim income figures collectively raise the risk premium.

Key catalysts and monitorables (next 12 months)

MonitorableWhy it mattersExpected timing
Q2 FY2027 resultsTest of post-provision earnings run-rateOct–Nov 2026 (trading window closed from 22 Sep 2026)
Further credit provisions / recoveriesValidates or undermines lending pivotEach quarter
Interest income vs. trading income mixSignals strategic directionEach quarter
Board strengthening (new independent directors)Governance and LODR comfortOngoing
Disclosure of "expansion plans"Potential re-rating triggerUnspecified
Shareholding changes among top holders (Bhaijee 16.73%, Sunil Kumar 14.27%)Control dynamicsQuarterly shareholding filings
Exchange surveillance actionsLiquidity/sentiment riskAd hoc
FY2027 annual report (Ind AS second year)Clean comparatives; risk-section disclosureAug–Sep 2027

Analyst verdict

Bampsl Securities is a 30-year-old, BSE-listed NBFC that functions as a compact, promoter-managed proprietary trading and lending vehicle. Its defining financial features are a debt-free ₹40 Cr balance sheet, two employees, gross trading revenue that has scaled impressively since FY2022 but at very thin margins, and a return on equity that has never exceeded 3.5% in the twelve years of available data. FY2026 marked a genuine strategic inflection: interest income rose roughly eighteen-fold as long-term loans reached ₹32.6 Cr, or about four-fifths of total assets. That same year also delivered the first test of the new strategy's risk, a ₹2.5 Cr bad-debt provision that wiped out most of the year's profit and produced a Q4 loss.

The investment question therefore reduces to credit quality, and on that question public disclosure is close to silent. Borrower identity, concentration, collateral, tenor and the provisioning methodology are not visible in accessed materials; the company issues no investor communications; and several interim figures in aggregator summaries do not reconcile with annual totals, compounded by a resubmission of Q1 FY2027 results. Governance signals are mixed: the promoter's shares are unencumbered, auditors gave an unmodified opinion, and investor grievances are nil, but the promoter owns only 10.83%, two outside holders each own more, the Chairman is also the MD, and the board has lost four directors since early 2024.

At roughly 1.5 times book value and about 150 times trailing earnings, the market is already capitalising a sustained improvement in profitability that the record does not yet support. A rerating case requires several consecutive quarters of clean lending income without further provisions, plus better disclosure. Until then, Bampsl is best regarded as a high-risk, illiquid, disclosure-constrained nano-cap whose valuation outruns its demonstrated returns; position sizing, if any, should reflect that the principal risks are credit and governance rather than market direction.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleIn role sinceAgePrior roles / educationSource

Bhisham Kumar Gupta

Chairman & Managing Director (Executive); sole promoter

MD/CEO Feb 2006; Chairman Nov 2010

62 (per MarketScreener)

Co-founding promoter (1995); over 22 years' securities-market experience at time of profile; education not disclosed in accessed sources

MarketScreener; Zonebourse; Kotak

Vinod Kumar Sharma

Director of Finance / CFO

May 2017

——

MarketScreener

Prerna Bajaj

Company Secretary & Compliance Officer

Feb 2021

——

MarketScreener; IIFL

“—” = not publicly disclosed.

Board of Directors

NameCategoryDINSinceStatus / notesSource

Bhisham Kumar Gupta

Executive Chairman & MD, promoter

—

2006 (MD)

Active

IIFL; MarketScreener

Sheela Gupta

Non-Executive Director (co-founding promoter group member at incorporation)

—

Zonebourse: 22 Jun 2015; ScanX: appointed 4 Aug 2025

Re-appointed on rotation at 29 Sep 2026 AGM

IIFL; ScanX

Sanjay Sharma

Independent Non-Executive Director

—

Mar 2017

Active

IIFL; MarketScreener

Sachin Singhal

Independent Director

08,293,304

Jun 2021 (Zonebourse)

Re-appointed for second 5-year term from 19 Jun 2026; approved at 2026 AGM

ScanX

Chetna Pandey

Independent Non-Executive Director

08,164,720

Jun 2018

Resigned 24 Oct 2025 (other assignments)

ScanX

Preeti Sharma

Independent Director

08,763,6742025

Resigned effective 28 Feb 2026 (personal reasons)

ScanX; blinkx

Vinubhai Prabhudas Patel

Director

——

Resigned 4 Aug 2025

ScanX

Divit Agarwal

Director

——

Resigned (announced 3 Mar 2024)

MarketScreener

Shareholding Trend

Holder categoryFY2022FY2023FY2024FY2025FY2026

Promoter holding (%)

10.8310.8310.8310.8310.83

Public holding (%)

89.1789.1689.1789.1789.18

FII holding (%)

00000

DII holding (%)

00000

Number of shareholders

7,6866,9308,0298,7977,880

Major Shareholders

RankHolderCategorySharesStake (%)
1

Bhai Ji Broking and Investment Pvt Ltd (also shown as Bhaijee Broking and Investments Pvt Ltd / Bhaijee Portfolio)

Public – body corporate

5,694,25116.73
2

Sunil Kumar

Public – individual

4,855,98014.27
3

Bhisham Kumar Gupta

Promoter

3,686,58810.83
4

Sanjay Gupta

Public – individual

1,001,4112.94
5

Usha Gupta

Public – individual

884,4442.60
6

Arpit Gupta

Public – individual

856,3852.52
7

Satish Kumar Gupta

Public – individual

632,5001.86
8

Sahil Gupta

Public – individual

615,2501.81
9

Surendra Kumar Gupta

Public – individual

366,9821.08
10

Mata Deen Gupta

Public – individual

355,7611.05
11

Nishil Gupta

Public – individual

344,0751.01

Competitive Landscape

Key Competitors

Peer (as named by vendors)Peer-list sourceRelative positioning

Williamson Magor & Co

Business Standard (2024)

Investment company

Bervin Investment & Leasing

Business Standard (2024)

Small NBFC

Indus Finance

Business Standard (2024)

Small NBFC

India Cements Capital

Business Standard (2024)

Financial services

Qgo Finance

Business Standard (2024)

Small NBFC

JMD Ventures

Business Standard (2024)

Nano-cap finance

Transcorp International

Business Standard (2025)

Forex/financial services

Prime Industries

Business Standard (2025)

Nano-cap

Dhansafal Finserve

Business Standard (2025)

Small NBFC

Banas Finance

Business Standard (2025)

Small NBFC/investment

Aastamangalam Finance

Business Standard (2025)

Small NBFC

Everlon Financials

Business Standard (2025)

Small NBFC

Competitor Detail

MetricBampsl (FY2026)

Revenue (INR Cr)

25.22

Revenue growth YoY (%)

6.8

Pre-tax margin (%)

2.4

Net margin (%)

1.6

R&D intensity (%)

Not disclosed (nil expected)

ROE (%)

1.0

Company Snapshot

$2.9M

Revenue

2

Employees

1995

Founded

New Delhi, India

Headquarters

SWOT Analysis

Strengths

  • Debt-free balance sheet: Borrowings were nil in every year FY2015–FY2026 (Screener); equity funds 99.5% of assets (FY2026).
  • Positive earnings record in recent years: Net profit positive in each of FY2021–FY2026 (₹0.02–1.35 Cr; Screener), with Q1 FY2027 PAT of ₹0.54 Cr.
  • Rapid top-line scaling: Revenue CAGR of ~116% over five years (FY2021–FY2026; Screener).
  • Licence and longevity: RBI NBFC registration since 25 May 1998 (IIFL) and BSE listing since February 1996.
  • Lean cost structure: Two employees (MarketScreener); depreciation rounded to ₹0.00 Cr in FY2025–FY2026 (Screener).
  • Clean auditor and grievance record: Unmodified audit opinion on FY2026 results (ScanX, May 2026); zero investor complaints certified for Q4 FY2026 and Q2 FY2027 (ScanX; Screener announcements); promoter shares unencumbered (31 Mar 2026 declaration).

Weaknesses

  • Very low returns: ROE between -1.29% and 3.48% across FY2015–FY2026; 3-year average 1.84% (Screener).
  • Thin margins: FY2026 pre-tax margin 2.4% and net margin 1.6% (analyst calc. from Screener).
  • Low promoter skin-in-the-game: Promoter holding 10.83%, unchanged since 2017 and below two non-promoter holders (Emkay, Mar 2026).
  • No dividends ever recorded in the 12-year series (Screener dividend payout 0% FY2015–FY2026).
  • Key-person and organisational fragility: Two employees; combined Chairman/MD role; board reduced to about four members after resignations (ScanX).
  • Weak operating cash generation: Operating cash flow negative in FY2025 (-₹2.74 Cr) and FY2026 (-₹0.08 Cr) (Screener).

Opportunities

  • Lending yield: FY2026 interest income of ₹3.49 Cr on ₹32.58 Cr long-term loans implies ~10.7% yield (analyst calc.); if credit costs normalise, lending could stabilise earnings.
  • Unlevered capacity: With zero debt and ₹39.9 Cr equity, modest leverage would mechanically lift ROE if risk-managed (analyst inference).
  • Retained-liquidity "expansion plans": Board cited liquidity for expansion in withholding the FY2026 dividend (ScanX, Sep 2026); disclosure of these plans could re-rate the stock.
  • Ind AS transition: Adopted from April 2025, potentially improving comparability with larger NBFCs (ScanX).
  • Shareholder base: 7,559 shareholders (Sep 2026) and ~89% public float give liquidity potential.
  • Q1 FY2027 recovery: PAT ₹0.54 Cr in one quarter, already above FY2026 full-year PAT of ₹0.40 Cr (Screener).

Threats

  • Credit losses: ₹2.50 Cr bad-debt provision in FY2026 exceeded pre-tax profit (ScanX).
  • Receivables build-up: Trade receivables +38.4% to ₹3.91 Cr (FY2026); debtor days 37.2 → 56.6 (ScanX; Screener).
  • Market-cycle dependence: Revenue fell 87% in FY2020 and 71% in FY2021 when market activity was weak (Screener); trading revenue fell 7.2% in FY2026.
  • Regulatory/surveillance scrutiny: BSE price-movement query, Nov 2025 (company letter).
  • Earnings volatility: Quarterly PAT swung from ₹0.60 Cr (Q3 FY2026) to -₹1.27 Cr (Q4 FY2026) (Screener).
  • Data/disclosure inconsistencies: Unreconciled H1 FY2026 income figure and a resubmission of Q1 FY2027 results (ScanX; Screener) raise reporting-quality questions for investors.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Ind AS becomes applicable ScanX (May 2026)Changes accounting basis; comparatives restated
20 May 2025FY2025 results reported (revenue ₹23.62 Cr; PAT ₹1.35 Cr) MarketScreener news log; ScreenerBest year in 12-year series
4 Aug 2025Board meeting: Sheela Gupta appointed Director; Vinubhai Prabhudas Patel resigns; Ankur Sharma appointed Secretarial Auditor ScanXGovernance change
Aug 2025Q1 FY2026 results (PAT ₹0.54 Cr) ScreenerStrong start to FY2026
16 Aug 2025Newspaper publication of results filed with BSE Nirmal BangRoutine compliance
25 Aug 2025Board meeting approving AGM notice Tickertape/Capital MarketRoutine
29 Sep 202530th AGM Tickertape/Capital MarketAdoption of FY2025 accounts
24 Oct 2025Q2 FY2026 results (PAT ₹52.59 lakh vs ₹54.83 lakh restated prior year); Independent Director Chetna Pandey resigns ScanXBoard shrinks; restated comparatives
21 Nov 2025BSE emails company seeking clarification on significant price movement Company letter to BSESurveillance attention
22 Nov 2025Company replies it is not aware of any undisclosed price-sensitive information Company letter to BSEPrice move attributed to market
18 Dec 2025Share price ₹21.03; 12-month gain 107.6%; 52-week range ₹9.80–₹25.49 Business StandardPeak-period valuation ~₹72 Cr
9 Feb 2026Q3 FY2026 results: total income ₹687.73 lakh, PAT ₹59.95 lakh; limited review by G.C. Agarwal & Associates ScanXThird consecutive profitable quarter
18 Feb 2026Intimation of resignation of Independent Director Preeti Sharma (personal reasons) ScanXFurther board attrition
28 Feb 2026Board accepts Preeti Sharma's resignation ScanXBoard reduced to ~4 members
31 Mar 2026Promoter declaration of no encumbrance for FY2026 Company filing via Value ResearchNo pledged shares
1 Apr 2026RTA certifies zero SEBI/BSE/shareholder complaints in Q4 FY2026 ScanXClean investor-grievance record
28 May 2026FY2026 results: PAT ₹40.07 lakh (-70%); Q4 net loss ₹126.80 lakh; unmodified audit opinion ScanXCredit-cost shock
30 May 2026Results publicised; revenue from operations ₹2,522.45 lakh ScanXTop line up 6.8%
9 Jun 2026Board meeting called to consider Singhal re-appointment ScanXGovernance continuity
19 Jun 2026Sachin Singhal re-appointed Independent Director for 5 years (subject to AGM) ScanXMaintains independent quorum
28 Jul 2026Intimation of board meeting for Q1 FY2027 results SharekhanRoutine
7 Aug 2026Q1 FY2027 results: PAT ₹53.58 lakh (-1.4% YoY); other operating income -58% ScanXEarnings normalise post-Q4 loss
14 Aug 2026Intimation of board meeting for AGM SharekhanRoutine
25 Aug 2026Board approves AGM notice and Directors' Report; book closure 22–30 Sep 2026; Ritika Agarwal named scrutinizer ScanXAGM logistics
4 Sep 2026FY2026 Annual Report filed under Reg. 34(1); ₹250 lakh bad-debt provision disclosed; no dividend ScanX; SharekhanPrimary disclosure of credit charge
11 Sep 2026Resubmission of Q1 FY2027 financial results to BSE Screener announcementsPossible correction of initial filing
22 Sep 2026Trading window closed until 48 hours after Q2 FY2027 results Screener announcementsResults due
29 Sep 202631st AGM: FY2026 accounts adopted; Sheela Gupta re-appointed; Singhal re-appointment approved ScanXGovernance continuity
11 Oct 2026Reg. 74(5) SEBI (DP) certificate for Q2 FY2027 Screener announcementsRoutine
17 Oct 2026RTA certifies no complaints for 1 Jul – 30 Sep 2026 Screener announcementsClean grievance record

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Revenue by Segment: Trading in Shares & Financing Services revenue rose from INR 3.1 Mn in FY2022 to INR 252.2 Mn in FY2026.
Bampsl Securities Limited — Revenue by Segment
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Trading in Shares & Financing Services revenue3.131.283.8236252.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Screener.in — BAMPSL Securities Ltd (standalone P&L, balance sheet, cash flow, ratios, shareholding, announcements, annual-report index)
  2. ScanX (Dhan) news log and filing summaries
  3. ScanX — FY2026 results, bad-debt charge (4 Sep 2026)
  4. ScanX — Q1 FY2027 results (7–8 Aug 2026)
  5. ScanX — Q2 FY2026 results and director resignation (24 Oct 2025)
  6. ScanX — Singhal re-appointment (19 Jun 2026)
  7. ScanX — Board meeting notice and FY2026 PAT (Jun 2026)
  8. Company letter to BSE on price movement (22 Nov 2025)
  9. Promoter no-encumbrance declaration (31 Mar 2026)
  10. Emkay Global — Shareholding pattern as on 31 Mar 2026
  11. Bajaj Broking — shareholding and price data
  12. Bajaj Finserv — shareholding (earlier period)
  13. Simply Wall St — ownership
  14. IIFL / IndiaInfoline — company summary, directors, Directors' Report FY2025 · indiainfoline.com · indiainfoline.com
  15. MarketScreener — management, board, employees, news log
  16. Zonebourse — segment and geographic revenue, executives
  17. InstaFinancials (MCA data) — CIN, capital, registered office
  18. MarketsMojo — company CV, promoters, RTA
  19. Nirmal Bang — quote, registered office, NSE non-listing
  20. Business Standard — price, peers (Dec 2024: Dec 2025) · business-standard.com
  21. ICICIdirect — price, P/E, P/B (May & Jun 2026)
  22. Equitymaster — price and market cap (Apr 2024)
  23. Zerodha — valuation and peer median
  24. Musaffa — Shariah screen and key statistics
  25. Kotak Securities — company description
  26. Sharekhan — filing log (2026)
  27. Tickertape — board meeting/AGM news
  28. blinkx — board of directors
  29. Fyers — peer table and market cap
  30. Angel One — price (Oct 2025)
  31. BSE annual reports index (via Screener links), including FY2026 Annual Report: (direct retrieval blocked during research)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.